Inovio Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $65 | $116 | $0 |
Gross Profit | -741 | 65 | -658 | -765 |
EBITDA | -22,777 | -25,050,529 | -18,605 | -24,399 |
EBIT | -23,519 | -25,051,272 | -19,381 | -25,165 |
Net Income | -23,519 | -19,694 | -19,381 | -25,165 |
Net Change In Cash | 0 | 65 | 116 | 0 |
Free Cash Flow | -20,811,359 | -26,874,027 | -19,663 | -84,355 |
Cash | 24,351 | 39,915 | 65,813 | 21,687 |
Basic Shares | 38,830 | 27,160 | 27,160 | 28,140 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $217 | $832 | $10,262 | $1,774 |
Gross Profit | -2,912 | -2,671 | 4,766 | -2,956 |
EBITDA | -103,946 | -130,391 | -270,902 | -296,557 |
EBIT | -107,076 | -133,894 | -276,398 | -301,287 |
Net Income | -107,254 | -135,117 | -279,818 | -303,658 |
Net Change In Cash | 217 | 832 | 10,262 | 1,774 |
Cost of Revenue | -24,788 | -179,554 | ||
Free Cash Flow | -104,564 | -124,686 | -217,184 | -216,939 |
Cash | 65,813 | 14,310 | 46,329 | 71,143 |
Basic Shares | 27,160 | 22,173 | 19,885 | 214,622 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.61 |
2025-03-31 | -$0.51 |
2024-12-31 | -$0.60 |
2024-09-30 | -$0.89 |
